Sofregen Medical
PrivateLast Round
Series B
Dec 17, 2019
Total Funding Raised
$15.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Sofregen Medical operates in Healthcare & Life Sciences and is based in Framingham, Massachusetts. Its latest recorded funding round was a Series B round in December 2019.
Sofregen Medical is a biotechnology company that develops a platform of products based on silk protein for soft tissue support and regeneration.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sofregen Medical Comparables
Compare Sofregen Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merz | 81% | |
| APrevent Medical Inc. | 72% | |
| Serigen Mediproducts | 69% |
For institutional investors. Book with your work email.
Sofregen Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 17, 2019 | ||||
| Series A | Sep 15, 2016 | ||||
| Debt | Sep 15, 2016 | ||||
| Seed | Sep 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sofregen Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anzu Partners | Series B |
| Polaris Partners | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 5, representing 63% of headcount.
- May 15, 2026
Monthly visitors increased 47% MoM.
For institutional investors. Book with your work email.
Sofregen Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sofregen Medical's valuation, stock price, and market status.
Is Sofregen Medical a public or private company?
Sofregen Medical is a private company.
What is the current stock price of Sofregen Medical?
Sofregen Medical is a private company, so its shares have no public market price. Caplight tracks Sofregen Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sofregen Medical worth (valuation)?
Valuation information for Sofregen Medical is not publicly available.
Can I buy Sofregen Medical stock?
Sofregen Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sofregen Medical's last funding round?
Sofregen Medical's most recent funding round was Series B on December 17, 2019.
Who are the main investors in Sofregen Medical?
Key investors in Sofregen Medical include Anzu Partners, Polaris Partners.
Will Sofregen Medical IPO soon?
No public IPO plans have been announced for Sofregen Medical.
How can I track Sofregen Medical secondary market activity?
Caplight tracks bids, offers, and trades in Sofregen Medical's shares on secondary markets.